|
1
|
Activation of vascular endothelial growth factor through reactive oxygen species mediates 20-hydroxyeicosatetraenoic acid-induced endothelial cell proliferation.
|
J Pharmacol Exp Ther
|
2007
|
1.53
|
|
2
|
Inhibitors of cytochrome P450 4A suppress angiogenic responses.
|
Am J Pathol
|
2005
|
1.41
|
|
3
|
9L gliosarcoma cell proliferation and tumor growth in rats are suppressed by N-hydroxy-N'-(4-butyl-2-methylphenol) formamidine (HET0016), a selective inhibitor of CYP4A.
|
J Pharmacol Exp Ther
|
2005
|
1.19
|
|
4
|
Human U251 glioma cell proliferation is suppressed by HET0016 [N-hydroxy-N'-(4-butyl-2-methylphenyl)formamidine], a selective inhibitor of CYP4A.
|
J Pharmacol Exp Ther
|
2005
|
1.19
|
|
5
|
Expression of CYP4A1 in U251 human glioma cell induces hyperproliferative phenotype in vitro and rapidly growing tumors in vivo.
|
J Pharmacol Exp Ther
|
2008
|
1.03
|
|
6
|
20-HETE can act as a nonhypoxic regulator of HIF-1alpha in human microvascular endothelial cells.
|
Am J Physiol Heart Circ Physiol
|
2009
|
0.94
|
|
7
|
Role of NADPH oxidase and ANG II in diabetes-induced retinal leukostasis.
|
Am J Physiol Regul Integr Comp Physiol
|
2007
|
0.93
|
|
8
|
Central serous chorioretinopathy in African Americans.
|
J Natl Med Assoc
|
2003
|
0.88
|
|
9
|
The cytochrome P450 4A/F-20-hydroxyeicosatetraenoic acid system: a regulator of endothelial precursor cells derived from human umbilical cord blood.
|
J Pharmacol Exp Ther
|
2011
|
0.85
|
|
10
|
Role of angiotensin II in retinal leukostasis in the diabetic rat.
|
Exp Eye Res
|
2006
|
0.84
|
|
11
|
MRI retinovascular studies in humans: research in patients with diabetes.
|
NMR Biomed
|
2008
|
0.82
|
|
12
|
Evaluation of visual acuity measurements after autorefraction vs manual refraction in eyes with and without diabetic macular edema.
|
Arch Ophthalmol
|
2011
|
0.79
|